Thomas Hallam
Director of Finance/CFO bei GIVAUDAN SA
Vermögen: 3 Mio $ am 31.03.2024
Profil
Zurzeit ist Tom Hallam Chief Financial Officer bei Givaudan SA. Herr Hallam ist auch Mitglied des Chartered Institute of Management Accountants. In seiner früheren Laufbahn war Herr Hallam Vice President-Corporate Finance bei Serono SA. Herr Hallam erhielt einen Bachelor-Abschluss von der University of Manchester.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
GIVAUDAN SA
0,01% | 31.12.2023 | 594 ( 0,01% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Thomas Hallam
Unternehmen | Position | Beginn |
---|---|---|
GIVAUDAN SA | Director of Finance/CFO | 01.01.2017 |
AZELIS GROUP NV | Director/Board Member | 02.08.2022 |
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Corporate Officer/Principal | - |
Azelis SA
Azelis SA Wholesale DistributorsDistribution Services Azelis SA engages in distribution of specialty chemicals. Its services include sampling, logistics, application laboratories, reach regulation, and food development kitchens. It caters to the animal nutrition, food and health, home care and industrial cleaning, personal care, pharmaceutical, electronics, lubricants and metalworking fluids, oilfield, rubber and plastic additives, textiles, and leather and paper industries. The company was founded by Hans Udo Wenzel in 1996 and is headquartered in Munsbach, Luxembourg. | Director/Board Member | - |
Ehemalige bekannte Positionen von Thomas Hallam
Unternehmen | Position | Ende |
---|---|---|
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Corporate Officer/Principal | - |
Ausbildung von Thomas Hallam
The University of Manchester | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GIVAUDAN SA | Consumer Non-Durables |
AZELIS GROUP NV | Distribution Services |
Private Unternehmen | 3 |
---|---|
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Consumer Services |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
Azelis SA
Azelis SA Wholesale DistributorsDistribution Services Azelis SA engages in distribution of specialty chemicals. Its services include sampling, logistics, application laboratories, reach regulation, and food development kitchens. It caters to the animal nutrition, food and health, home care and industrial cleaning, personal care, pharmaceutical, electronics, lubricants and metalworking fluids, oilfield, rubber and plastic additives, textiles, and leather and paper industries. The company was founded by Hans Udo Wenzel in 1996 and is headquartered in Munsbach, Luxembourg. | Distribution Services |